Discover the future of glaucoma treatment with Hexiris at the BIO International Convention in San Diego, CA, June 3-6! Meet our co-founders, Dr. Nir Shoham-Hazon MD and Dr Houfar Sekhavat, and learn more about our cutting-edge MIGS 2.0 device. Join us as we redefine the treatment paradigm of glaucoma therapy and improve patient access to care. #BIO2024 #GlaucomaTreatment #MedicalDevices #OphthalmologyInnovation #BIOInternationalConvention
Hexiris’ Post
More Relevant Posts
-
Discover the impact of Rezum Water Vapour Therapy on patients with enlarged prostates. Dr. Borut Gubina walks you through how this approach is gaining traction among patients. Explore patient selection criteria, efficacy data, and gain his insights by watching the video. #BSCEMEA #BPH
To view or add a comment, sign in
-
Patient selection is key in #BPH
Discover the impact of Rezum Water Vapour Therapy on patients with enlarged prostates. Dr. Borut Gubina walks you through how this approach is gaining traction among patients. Explore patient selection criteria, efficacy data, and gain his insights by watching the video. #BSCEMEA #BPH
To view or add a comment, sign in
-
Exciting news from Biosplice! We're participating in the World Congress of Osteoarthritis (WCO) 2024, taking place from April 11th to 15th in London, UK. At this year's conference, we're excited to present our latest research findings: 🔹 Oral Presentation: "Radiographic and Pain Outcomes from a Phase 3 Extension Study (OA-07) Evaluating the Safety and Efficacy of Repeat Lorecivivint Injections Over 3 Years in Subjects with Severe Knee Osteoarthritis." 🔹 Oral Poster Presentation P674: "Treatment with Lorecivivint Leads to Improved Long-Term Patient Acceptable Symptom State (PASS) Compared to Placebo: Data from Phase 3 Extension Trial." These presentations highlight our ongoing commitment to advancing the treatment landscape for osteoarthritis and working to improve patient outcomes. #WCO2024 #Biosplice #London
To view or add a comment, sign in
-
Real-world data continues to demonstrate the efficacy of the hybrid convergent procedure in Advanced Afib patients. See the results of this innovative two-step approach first-hand by visiting: https://okt.to/ZNbKIh #HybridAFTherapy #Epeeps #CardiacSurgery
To view or add a comment, sign in
-
Two nice cases of VT ablation with strikingly similar clinical presentations: hypertrophic cardiomyopathy, similar ECG morphology, and apical origin. The only difference? One was ablated endocardially, the other epicardially! The high-resolution mid-diastolic signals targeted for ablation, recorded using the ablation catheter's microelectrodes, were particularly interesting. These signals allowed for acute termination of the clinical arrhythmia in both cases. Mazzone Patrizio Fabrizio Guarracini Matteo Baroni Sara Vargiu Alberto Preda Marco Carbonaro Antonio Frontera Raffaele Falco Francesco Panzeri Marisa Varrenti Giulia Colombo Alessio Testoni Mattia Vecchi Johnson & Johnson MedTech #epeeps #ventriculartachycardia #VTablation #cardiacablation #arrhythmia #hdmapping #qdot #optrell #carto
To view or add a comment, sign in
-
Boston Scientific has just closed the acquisition of Silk Road Medical, Inc. This is a game-changer for stroke prevention and carotid artery disease treatment! The innovative TCAR (transcarotid artery revascularization) platform from Silk Road Medical will now be part of Boston Scientific's extensive vascular technology solutions. This acquisition means Boston Scientific can now offer even more advanced options for patients dealing with carotid artery disease. The potential for reduced stroke risk and improved patient outcomes is huge. As Cat Jennings, President of Vascular, Peripheral Interventions at Boston Scientific, mentioned, this will truly expand their reach to more physicians and patients. It's a done deal! Nice to see M&A momentum as we make our way towards yearend. www.rinconsearchgroup.com #MedTech #HealthcareInnovation #CardiovascularCare
To view or add a comment, sign in
-
Curious about the latest updates from AURIMOD GmbH and what’s coming next? Check out our newsletter (in German) to learn about our company news, participation in recent and upcoming congresses, and exciting new partnerships and projects, including: - Raising awareness for chronic pain wih our new video campaign for the #painawarenessmonth - New reimbursement for auricular Vagus Nerve Stimulation (aVNS) in Austrian Hospitals - DFP-Webinar on aVNS in pain management Read the online version here: https://lnkd.in/dv9iZEbd Not a subscriber yet? Sign up for our newsletter here: https://lnkd.in/diNpemBV #newsletter #neuromodulation #painmanagement #chronicpain #vagusnerve
To view or add a comment, sign in
-
💡 Exciting technological advancements are reshaping venous thromboembolism (VTE) treatment! From novel anticoagulants that lower bleeding risks to catheter-directed thrombolysis innovations for precise clot removal, VTE care is becoming safer and more effective. Compression therapy continues to play a vital role in prevention, while patient outcomes and satisfaction are on the rise with new interventional therapies. 🚑🔬 💼 Dive into the trends and opportunities driving this dynamic market! 🌐 Visit rtvmed.com for more insights. #VTE #MedicalInnovation #Anticoagulants #Thrombolysis #CompressionTherapy #HealthcareTech #PatientCare #InterventionalTherapy #BleedingPrevention #PharmaBreakthroughs
To view or add a comment, sign in
-
DeQuervain's Tenosynovitis New patient seen today for evaluation of 2-year history of chronic right radial styloid pain. Exam and US are consistent with DeQuervain's. US imaging shows significantly enlarged APL and EPB tendons in the affected right side, especially when compared to the uninvolved left side. NOTE: The APL exists in multiple bundles in 80% of normal people! So be careful about making a diagnosis based solely on US imaging. For my diagnostic and interventional instructional MSK US videos, go to www.UltrasoundDocs.com! #deQuervain #DeQuervains #tenosynovitis #wristpain #US #EPB #APL
To view or add a comment, sign in
-
Practice guidelines and quality metrics are based on compelling science. AtriCure’s LeAAPS™ Trial is a pivotal initiative intended to evaluate the safety and effectiveness of surgical LAA exclusion to prevent stroke in patients with an elevated risk, but no history of Afib. Learn more about this groundbreaking trial: https://okt.to/9c304M #ClinicalTrial #leaaps #LAAE #stroke
To view or add a comment, sign in
397 followers